LGC Clinical Diagnostics

LGC Clinical Diagnostics is a strategic business unit within the larger LGC Group, focused on supplying essential quality assurance and component materials to the global in-vitro diagnostics (IVD) and clinical genomics markets. The company's integrated portfolio offers a comprehensive suite of products including reference materials, proficiency testing/EQA programs, custom reagent development, and viral antigens, which are critical for validating assays, ensuring laboratory compliance, and advancing research. By consolidating four established brands under one umbrella, it provides a one-stop-shop for diagnostic developers and clinical labs seeking to improve test accuracy and accelerate innovation. Its mission centers on enabling 'Science for a Safer World' by supporting reliable disease diagnosis and treatment.

Integrated portfolio providing diagnostic quality solutions: reference materials & controls (Seraseq®, etc.), proficiency testing/external quality assessment (Certus EQA), reagent components & biologicals (viral antigens), and custom development services for assay validation and quality control.

The company competes with other specialized providers of reference materials and proficiency testing (e.g., ZeptoMetrix, Bio-Rad's QC division), as well as in-house solutions developed by large diagnostic manufacturers. Its competitive advantage lies in its broad, integrated portfolio and custom development capabilities, offering a comprehensive solution set.